| Philip Nibley, MD | |
|
6501 Coyle Ave, Carmichael, CA 95608-0306 | |
| (916) 864-5753 | |
| Not Available |
| Full Name | Philip Nibley |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 9 Years |
| Location | 6501 Coyle Ave, Carmichael, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1275910770 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | A154947 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy San Juan Medical Center | Carmichael, CA | Hospital |
| Sutter Auburn Faith Hospital | Auburn, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Cep America - California | 6103739131 | 954 |
News Archive
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company today announced that data regarding retreatment experiences with brentuximab vedotin in phase I and phase II clinical trials will be presented during a poster session at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO) being held June 4-8, 2010 in Chicago, Illinois.
The Center for Global Health and Development (CGHD) at Boston University on Thursday delivered its report on the President's Malaria Initiative (PMI), released in February, to the U.S. Congress, IIP Digital reports, noting the "independent evaluation team finds that the [PMI] has been 'very successful' in reducing children's deaths from the mosquito-borne parasitic disease, but also warns that the program must gear up if those gains are to be sustained."
Now all foster children in Australia for the first time will receive individual plans detailing the support they need after leaving care. This comes under the new national scheme wherein uniform standards in meeting each child's requirements at the time of entering foster care will be ensured. At present child protection systems are different for each of the states and territories. This scheme will unite them all.
Poniard Pharmaceuticals, Inc. today announced updated clinical data from its randomized, controlled Phase 2 trial of picoplatin in patients with metastatic colorectal cancer (CRC).
› Verified 2 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023063542 PECOS PAC ID: 6103739131 Enrollment ID: O20031106000520 |
News Archive
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company today announced that data regarding retreatment experiences with brentuximab vedotin in phase I and phase II clinical trials will be presented during a poster session at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO) being held June 4-8, 2010 in Chicago, Illinois.
The Center for Global Health and Development (CGHD) at Boston University on Thursday delivered its report on the President's Malaria Initiative (PMI), released in February, to the U.S. Congress, IIP Digital reports, noting the "independent evaluation team finds that the [PMI] has been 'very successful' in reducing children's deaths from the mosquito-borne parasitic disease, but also warns that the program must gear up if those gains are to be sustained."
Now all foster children in Australia for the first time will receive individual plans detailing the support they need after leaving care. This comes under the new national scheme wherein uniform standards in meeting each child's requirements at the time of entering foster care will be ensured. At present child protection systems are different for each of the states and territories. This scheme will unite them all.
Poniard Pharmaceuticals, Inc. today announced updated clinical data from its randomized, controlled Phase 2 trial of picoplatin in patients with metastatic colorectal cancer (CRC).
› Verified 2 days ago
| Entity Name | Cep America - California |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1548667843 PECOS PAC ID: 6103739131 Enrollment ID: O20040121000458 |
News Archive
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company today announced that data regarding retreatment experiences with brentuximab vedotin in phase I and phase II clinical trials will be presented during a poster session at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO) being held June 4-8, 2010 in Chicago, Illinois.
The Center for Global Health and Development (CGHD) at Boston University on Thursday delivered its report on the President's Malaria Initiative (PMI), released in February, to the U.S. Congress, IIP Digital reports, noting the "independent evaluation team finds that the [PMI] has been 'very successful' in reducing children's deaths from the mosquito-borne parasitic disease, but also warns that the program must gear up if those gains are to be sustained."
Now all foster children in Australia for the first time will receive individual plans detailing the support they need after leaving care. This comes under the new national scheme wherein uniform standards in meeting each child's requirements at the time of entering foster care will be ensured. At present child protection systems are different for each of the states and territories. This scheme will unite them all.
Poniard Pharmaceuticals, Inc. today announced updated clinical data from its randomized, controlled Phase 2 trial of picoplatin in patients with metastatic colorectal cancer (CRC).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Philip Nibley, MD 3518 Bodega Ct, Sacramento, CA 95864-2802 Ph: (801) 722-8704 | Philip Nibley, MD 6501 Coyle Ave, Carmichael, CA 95608-0306 Ph: (916) 864-5753 |
News Archive
Seattle Genetics, Inc. and Millennium: The Takeda Oncology Company today announced that data regarding retreatment experiences with brentuximab vedotin in phase I and phase II clinical trials will be presented during a poster session at the 2010 Annual Meeting of the American Society of Clinical Oncology (ASCO) being held June 4-8, 2010 in Chicago, Illinois.
The Center for Global Health and Development (CGHD) at Boston University on Thursday delivered its report on the President's Malaria Initiative (PMI), released in February, to the U.S. Congress, IIP Digital reports, noting the "independent evaluation team finds that the [PMI] has been 'very successful' in reducing children's deaths from the mosquito-borne parasitic disease, but also warns that the program must gear up if those gains are to be sustained."
Now all foster children in Australia for the first time will receive individual plans detailing the support they need after leaving care. This comes under the new national scheme wherein uniform standards in meeting each child's requirements at the time of entering foster care will be ensured. At present child protection systems are different for each of the states and territories. This scheme will unite them all.
Poniard Pharmaceuticals, Inc. today announced updated clinical data from its randomized, controlled Phase 2 trial of picoplatin in patients with metastatic colorectal cancer (CRC).
› Verified 2 days ago
Lara Zibners, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 3620 Kiekebusch Ct, Carmichael, CA 95608 Phone: 916-944-2501 | |
Dr. Dean Kim, M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 4156 Manzanita Ave, Suite 100, Carmichael, CA 95608 Phone: 916-483-5400 Fax: 916-483-1937 | |
John Wood, DO Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6501 Coyle Ave, Carmichael, CA 95608 Phone: 330-493-4443 | |
Andrew Lawrence Griffin, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 6501 Coyle Ave, Carmichael, CA 95608 Phone: 916-864-5550 | |
Benjamin David Jones, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6501 Coyle Ave, Carmichael, CA 95608 Phone: 916-537-5000 | |
James Goldberg, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 6501 Coyle Ave, Carmichael, CA 95608 Phone: 330-493-4443 |